Most Popular Stories
- Hospitals lose reimbursement for 'unnecessary' ER visits
- Healthcare jobs will grow the fastest of all industries
- Online tools, social media ease clinical recruiting, research
- Hospital exec arrested in $116M Medicare scheme
- Patient satisfaction equal for physician, hospitalist care
- New Hospital Compare data shows disparity in blood infection rates
Featured Jobs
-
Electronic Health Records Application Support Manager RN-New Year New Career
Avanti on behalf of Respected Health System - San Francisco, CA -
Epic Ambulatory Beacon Consultant
Meditology Services - NC -
ICD-10 Revenue Cycle, Manager
Meditology Services - Atlanta, GA
Events
- Medical Devices Summit 2012
March 6-7 2012 — The Boston Park Plaza Hotel & Towers, Boston, MA - From IHI: The Patient Experience Seminar
March 27-28 — Boston, MA - ICD-10 Reality Check - Breakfast Panel at HiMSS 2012!
February 22, 2012 - AHIP's Institute 2012
June 20-22 — Salt Lake City, UT
Paid Research Reports
- Electronic health records: getting it right first time
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Stakeholder Opinions: Ophthalmology - Leading brands under threat
- Genomics, Proteomics and Metabolomics in Diagnostics: Market landscape, innovative technologies and future outlook
- Healthcare Regulatory Update: The United Arab Emirates
- Point of Care Testing: Evaluating the return to evidence based medicine, novel technologies and the competitive landscape
Free Newsletter
FierceHealthcare is the leading source of healthcare management news for healthcare industry executives. Join 50,000+ healthcare industry insiders who get FierceHealthcare via daily email. Sign up today!
Popular Topics
Boston Scientific, Medtronic slammed with renewed $600M award
Eight years ago, Johnson & Johnson division Cordis Corp. was awarded almost $600 million in damages in a cardiac-stent infringement case against Boston Scientific Corp. and Medtronic. The cases involved the patent on Cordis's original Palmaz balloon expandable stent. However, the damages were set aside in 2000 and against in 2005 after successful appeals to jury verdicts in the cases. Now, a judge in Delaware has reinstated the awards, putting Boston Scientific on the hook for $324 million plus interest and Medtronic for $271 million plus interest.
To learn more about the case:
- read this Modern Healthcare article (reg. req.)
- read this Johnson & Johnson press release
Related Stories
- U.S. Senator questions partnership between cardiologists, medical devicemaker-backed group
- Drug companies plan to disclose grant funding
- Cardiologists stand by stents
- Defibrillator market faces problems
- Cambridge Heart Test wins Medicare approval
- Law could hurt device makers
- Guidant Merger Signifies Technological Shift
- Guidant competition leads to talk of St. Jude takeover
- Medtronic enters drug-eluting stent market
- Senate Finance probes Medtronic contract cancellations
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site Map
| Editors | List in Marketplace | Supplier in MarketplaceTHE FIERCEMARKETS NETWORKFierceEnergy | FierceSmartGrid | FierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceHealthPayer | FiercePracticeManagement | FierceEMR | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceGovernment | FierceHomelandSecurity | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceMedicalDevices | FierceDrugDelivery | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceEnterpriseCommunications | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe | FierceCable© 2011 FierceMarkets. All rights reserved. |
![]() |
